Intimation Under Regulation 30 of SEBI ( Listing Obligation and Disclosure Requirements ) Regulations, 2015 - Selection of Veterinary Products for Supply to Amul

Business Updates View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.0%Reaction day

₹42.50

prior close

—

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.8%+2.8% vs market

Pharmaceuticals peers, median of 147sector-0.9%+2.9% vs sector

On the reaction day the stock moved 2.8 pts more than Nifty Microcap 250 and 2.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.0-0.8+2.8-0.9+2.9

Next day

+2.2-0.7+2.8-0.6+2.8

+0.0-0.6+0.6-0.3+0.3

+3.5+0.0+3.5-0.6+4.1

—-0.8—-0.6—

+7.8+0.7+7.0-0.9+8.6

+8.3+1.9+6.4-0.1+8.4

15d

+6.1+0.9+5.2-0.8+7.0

+8.9+1.7+7.2-1.0+9.9

+4.7+0.2+4.5-1.3+6.0

+3.8+0.8+2.9-4.7+8.5

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 147Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Shelter Pharma Ltd has informed BSE that 14 of its veterinary products have been officially selected for supply to Gujarat Co-operative Milk Marketing Federation Ltd, commonly known as AMUL. The company describes this as a significant step in its growth within the animal healthcare sector, focusing on Ayurvedic welfare solutions for the dairy industry. The filing was made under SEBI Listing Obligations Regulation 30. No specific financial value, order size, or revenue impact has been disclosed in the announcement.

Likely market impact

This is a positive business development for Shelter Pharma, potentially opening up a large distribution channel through AMUL's dairy network, though the lack of disclosed order value makes it hard to gauge the actual financial impact on the stock.